| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 09/18/2023 | 13.08% | Wells Fargo | $140 → $126 | Maintains | Overweight |
| 07/31/2023 | 29.23% | TD Cowen | $123 → $144 | Maintains | Outperform |
| 07/31/2023 | 7.69% | Truist Securities | $106 → $120 | Maintains | Hold |
| 07/31/2023 | 12.18% | Barclays | $108 → $125 | Maintains | Equal-Weight |
| 07/28/2023 | 13.97% | Stifel | $125 → $127 | Maintains | Buy |
| 07/13/2023 | 12.18% | Stifel | $110 → $125 | Maintains | Buy |
| 06/12/2023 | 7.69% | Jefferies | $115 → $120 | Maintains | Buy |
| 06/07/2023 | -1.28% | B of A Securities | $105 → $110 | Maintains | Neutral |
| 05/31/2023 | -3.08% | Barclays | $107 → $108 | Maintains | Equal-Weight |
| 02/23/2023 | -5.77% | B of A Securities | → $105 | Maintains | Neutral |
| 02/02/2023 | 4.1% | Morgan Stanley | $118 → $116 | Maintains | Overweight |
| 02/01/2023 | -1.28% | Wells Fargo | $109 → $110 | Maintains | Overweight |
| 01/03/2023 | 5.9% | Morgan Stanley | $110 → $118 | Maintains | Overweight |
| 12/14/2022 | -1.28% | Morgan Stanley | $105 → $110 | Maintains | Overweight |
| 11/07/2022 | -2.18% | Wells Fargo | $100 → $109 | Maintains | Overweight |
| 10/31/2022 | 10.38% | Cowen & Co. | $109 → $123 | Maintains | Outperform |
| 10/31/2022 | -4.87% | Truist Securities | $100 → $106 | Maintains | Hold |
| 10/19/2022 | — | Raymond James | Downgrades | Outperform → Market Perform | |
| 09/13/2022 | -5.77% | Stifel | $102 → $105 | Maintains | Buy |
| 08/02/2022 | -5.77% | Morgan Stanley | $100 → $105 | Maintains | Overweight |
| 08/01/2022 | -10.26% | Truist Securities | $80 → $100 | Maintains | Hold |
| 08/01/2022 | -10.26% | Wells Fargo | $98 → $100 | Maintains | Overweight |
| 08/01/2022 | -1.28% | Raymond James | $96 → $110 | Maintains | Outperform |
| 06/14/2022 | -7.57% | Cowen & Co. | $109 → $103 | Maintains | Outperform |
| 06/08/2022 | — | Barclays | Downgrades | Overweight → Equal-Weight | |
| 06/07/2022 | -14.74% | Barclays | $95 → $95 | Downgrades | Overweight → Equal-Weight |
| 06/06/2022 | -10.26% | Morgan Stanley | $94 → $100 | Maintains | Overweight |
| 05/25/2022 | -15.64% | Morgan Stanley | $93 → $94 | Maintains | Overweight |
| 05/25/2022 | -13.85% | Raymond James | $90 → $96 | Maintains | Outperform |
| 04/14/2022 | -8.46% | Goldman Sachs | $83 → $102 | Maintains | Buy |
| 04/13/2022 | — | Goldman Sachs | Upgrades | Neutral → Buy | |
| 03/24/2022 | -12.05% | Wells Fargo | $90 → $98 | Maintains | Overweight |
| 03/18/2022 | -13.85% | Stifel | → $96 | Reinstates | → Buy |
| 03/11/2022 | -19.23% | B of A Securities | → $90 | Upgrades | Underperform → Neutral |
| 02/04/2022 | -14.74% | Barclays | $105 → $95 | Maintains | Overweight |
| 02/01/2022 | -16.54% | Morgan Stanley | $98 → $93 | Maintains | Overweight |
| 01/31/2022 | -28.21% | B of A Securities | $100 → $80 | Downgrades | Buy → Underperform |
| 01/31/2022 | -19.23% | Raymond James | → $90 | Upgrades | Market Perform → Outperform |
| 01/24/2022 | -5.77% | Barclays | $90 → $105 | Upgrades | Equal-Weight → Overweight |
| 11/02/2021 | -12.05% | Morgan Stanley | $97 → $98 | Maintains | Overweight |
| 11/01/2021 | -11.15% | Wells Fargo | $96 → $99 | Maintains | Overweight |
| 09/16/2021 | -10.26% | Cowen & Co. | $93 → $100 | Maintains | Outperform |
| 08/02/2021 | -21.03% | Truist Securities | $80 → $88 | Maintains | Hold |
| 06/18/2021 | -12.95% | Morgan Stanley | $94 → $97 | Maintains | Overweight |
| 06/09/2021 | -15.64% | Morgan Stanley | $90 → $94 | Maintains | Overweight |
| 05/13/2021 | -13.85% | Wells Fargo | → $96 | Initiates Coverage On | → Overweight |
| 05/12/2021 | -23.72% | Barclays | $78 → $85 | Maintains | Equal-Weight |
| 02/22/2021 | -19.23% | Morgan Stanley | $98 → $90 | Maintains | Overweight |
| 02/19/2021 | 133.33% | Barclays | → $260 | Reinstates | → Overweight |
| 02/19/2021 | -19.23% | Morgan Stanley | $98 → $90 | Maintains | Overweight |
| 12/04/2020 | -18.33% | Morgan Stanley | $87 → $91 | Maintains | Overweight |
| 11/02/2020 | -21.92% | Credit Suisse | $91 → $87 | Maintains | Outperform |
| 08/03/2020 | -21.92% | Morgan Stanley | $84 → $87 | Maintains | Overweight |
| 07/08/2020 | — | Raymond James | Downgrades | Outperform → Market Perform | |
| 05/27/2020 | -27.31% | JP Morgan | $69 → $81 | Maintains | Neutral |
| 05/19/2020 | -26.41% | Wells Fargo | $77 → $82 | Maintains | Overweight |
| 04/20/2020 | -29.1% | Goldman Sachs | $88 → $79 | Downgrades | Buy → Neutral |
| 04/14/2020 | -24.62% | SunTrust Robinson Humphrey | $88 → $84 | Maintains | Buy |
| 04/14/2020 | -24.62% | Morgan Stanley | $79 → $84 | Maintains | Overweight |
| 04/02/2020 | -30.9% | Wells Fargo | $81 → $77 | Maintains | Overweight |
| 04/02/2020 | -23.72% | Stifel | $90 → $85 | Downgrades | Buy → Hold |
| 03/03/2020 | -27.31% | Wells Fargo | → $81 | Upgrades | Equal-Weight → Overweight |
| 01/29/2020 | -29.1% | Wells Fargo | $76 → $79 | Maintains | Equal-Weight |
| 10/10/2019 | -30% | Morgan Stanley | $76 → $78 | Maintains | Overweight |
| 09/26/2019 | -23.72% | Cowen & Co. | $75 → $85 | Maintains | Outperform |
| 09/24/2019 | -30.9% | JP Morgan | → $77 | Initiates Coverage On | → Neutral |
| 09/20/2019 | -30.9% | Barclays | → $77 | Initiates Coverage On | → Equal-Weight |
| 08/21/2019 | -31.8% | Morgan Stanley | $70 → $76 | Maintains | Overweight |
| 07/30/2019 | -36.28% | Citigroup | $65 → $71 | Maintains | Neutral |
| 07/30/2019 | -33.59% | Wells Fargo | $71 → $74 | Downgrades | Outperform → Market Perform |
| 06/03/2019 | -37.18% | Morgan Stanley | → $70 | Initiates Coverage On | → Overweight |
| 05/09/2019 | -35.39% | Goldman Sachs | → $72 | Initiates Coverage On | → Buy |
| 10/30/2018 | -49.74% | Credit Suisse | $53 → $56 | Maintains | Outperform |
| 10/30/2018 | -50.64% | Wells Fargo | $50 → $55 | Maintains | Outperform |
| 10/30/2018 | -53.33% | Citigroup | $46 → $52 | Maintains | Neutral |
What is the target price for Booz Allen Hamilton (BAH)?
The latest price target for Booz Allen Hamilton (NYSE: BAH) was reported by Wells Fargo on September 18, 2023. The analyst firm set a price target for $126.00 expecting BAH to rise to within 12 months (a possible 13.08% upside). 18 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Booz Allen Hamilton (BAH)?
The latest analyst rating for Booz Allen Hamilton (NYSE: BAH) was provided by Wells Fargo, and Booz Allen Hamilton maintained their overweight rating.
When is the next analyst rating going to be posted or updated for Booz Allen Hamilton (BAH)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Booz Allen Hamilton, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Booz Allen Hamilton was filed on September 18, 2023 so you should expect the next rating to be made available sometime around September 18, 2024.
Is the Analyst Rating Booz Allen Hamilton (BAH) correct?
While ratings are subjective and will change, the latest Booz Allen Hamilton (BAH) rating was a maintained with a price target of $140.00 to $126.00. The current price Booz Allen Hamilton (BAH) is trading at is $111.43, which is out of the analyst's predicted range.